![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Greater sequence diversity during early hepatitis B virus decline on vebicorvir plus entecavir is associated with a lower level of virus rebound following switch to entecavir monotherapy
|
|
|
EASL 2022 June 22-26 London
Lewyn Li1, Peter A Revill2, Ran Yan1, Calvin Chan1, Hua Tian1, Julie Ma1, Luisa M Stamm1, Man-Fung Yuen3, Alexander Thompson4, Kathryn M Kitrinos1
1Assembly Biosciences, Inc., South San Francisco, CA, USA; 2Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia; 3Department of Medicine, The University of Hong Kong, Hong Kong; 4St. Vincent's Hospital, Melbourne, Fitzroy VIC, Australia
![0705221](../images/070522/070522-4/0705221.gif)
![0705222](../images/070522/070522-4/0705222.gif)
![0705223](../images/070522/070522-4/0705223.gif)
![0705224](../images/070522/070522-4/0705224.gif)
![0705225](../images/070522/070522-4/0705225.gif)
![0705226](../images/070522/070522-4/0705226.gif)
![0705227](../images/070522/070522-4/0705227.gif)
![0705228](../images/070522/070522-4/0705228.gif)
![0705229](../images/070522/070522-4/0705229.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|